Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Marnix Lameijer; Tina Binderup; Mandy M.T. van Leent; Max L. Senders; Francois Fay; Joost Malkus; Brenda L. Sanchez-Gaytan; Abraham J.P. Teunissen; Nicolas Karakatsanis; Philip Robson; Xianxiao Zhou; Yuxiang Ye; Gregory Wojtkiewicz; Jun Tang; Tom T.P. Seijkens; Jeffrey Kroon; Erik S.G. Stroes; Andreas Kjaer; Jordi Ochando; Thomas Reiner; Carlos Pérez-Medina; Claudia Calcagno; Edward A. Fisher; Bin Zhang; Ryan E. Temel; Filip K. Swirski; Matthias Nahrendorf; Zahi A. Fayad; Esther Lutgens; Willem J.M. Mulder; Raphaël Duivenvoorden

doi:10.1038/s41551-018-0281-3

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Marnix Lameijer, Tina Binderup, Mandy M.T. van Leent, Max L. Senders, Francois Fay, Joost Malkus, Brenda L. Sanchez-Gaytan, Abraham J.P. Teunissen, Nicolas Karakatsanis, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz, Jun Tang, Tom T.P. Seijkens, Jeffrey Kroon, Erik S.G. Stroes, Andreas Kjaer, Jordi Ochando, Thomas ReinerCarlos Pérez-Medina, Claudia Calcagno, Edward A. Fisher, Bin Zhang, Ryan E. Temel, Filip K. Swirski, Matthias Nahrendorf, Zahi A. Fayad, Esther Lutgens, Willem J.M. Mulder, Raphaël Duivenvoorden

Cardiovascular Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

Original language	English (US)
Pages (from-to)	623
Number of pages	1
Journal	Nature Biomedical Engineering
Volume	2
Issue number	8
DOIs	https://doi.org/10.1038/s41551-018-0281-3
State	Published - Aug 1 2018

ASJC Scopus subject areas

Biotechnology
Bioengineering
Medicine (miscellaneous)
Biomedical Engineering
Computer Science Applications

Access to Document

10.1038/s41551-018-0281-3

Fingerprint

Dive into the research topics of 'Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)'. Together they form a unique fingerprint.

Cite this

Lameijer, M., Binderup, T., van Leent, M. M. T., Senders, M. L., Fay, F., Malkus, J., Sanchez-Gaytan, B. L., Teunissen, A. J. P., Karakatsanis, N., Robson, P., Zhou, X., Ye, Y., Wojtkiewicz, G., Tang, J., Seijkens, T. T. P., Kroon, J., Stroes, E. S. G., Kjaer, A., Ochando, J., ... Duivenvoorden, R. (2018). Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2). Nature Biomedical Engineering, 2(8), 623. https://doi.org/10.1038/s41551-018-0281-3

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2). / Lameijer, Marnix; Binderup, Tina; van Leent, Mandy M.T. et al.
In: Nature Biomedical Engineering, Vol. 2, No. 8, 01.08.2018, p. 623.

Research output: Contribution to journal › Comment/debate › peer-review

Lameijer, M, Binderup, T, van Leent, MMT, Senders, ML, Fay, F, Malkus, J, Sanchez-Gaytan, BL, Teunissen, AJP, Karakatsanis, N, Robson, P, Zhou, X, Ye, Y, Wojtkiewicz, G, Tang, J, Seijkens, TTP, Kroon, J, Stroes, ESG, Kjaer, A, Ochando, J, Reiner, T, Pérez-Medina, C, Calcagno, C, Fisher, EA, Zhang, B, Temel, RE, Swirski, FK, Nahrendorf, M, Fayad, ZA, Lutgens, E, Mulder, WJM & Duivenvoorden, R 2018, 'Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)', Nature Biomedical Engineering, vol. 2, no. 8, pp. 623. https://doi.org/10.1038/s41551-018-0281-3

@article{c6aba9833b9a4098b41aa3e3dd2aafa0,

title = "Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)",

abstract = "In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as {\textquoteleft}Fischer{\textquoteright}. This has now been corrected.",

author = "Marnix Lameijer and Tina Binderup and {van Leent}, {Mandy M.T.} and Senders, {Max L.} and Francois Fay and Joost Malkus and Sanchez-Gaytan, {Brenda L.} and Teunissen, {Abraham J.P.} and Nicolas Karakatsanis and Philip Robson and Xianxiao Zhou and Yuxiang Ye and Gregory Wojtkiewicz and Jun Tang and Seijkens, {Tom T.P.} and Jeffrey Kroon and Stroes, {Erik S.G.} and Andreas Kjaer and Jordi Ochando and Thomas Reiner and Carlos P{\'e}rez-Medina and Claudia Calcagno and Fisher, {Edward A.} and Bin Zhang and Temel, {Ryan E.} and Swirski, {Filip K.} and Matthias Nahrendorf and Fayad, {Zahi A.} and Esther Lutgens and Mulder, {Willem J.M.} and Rapha{\"e}l Duivenvoorden",

note = "Publisher Copyright: {\textcopyright} 2018, The Publisher.",

year = "2018",

month = aug,

day = "1",

doi = "10.1038/s41551-018-0281-3",

language = "English (US)",

volume = "2",

pages = "623",

journal = "Nature Biomedical Engineering",

issn = "2157-846X",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Erratum to

T2 - Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

AU - Lameijer, Marnix

AU - Binderup, Tina

AU - van Leent, Mandy M.T.

AU - Senders, Max L.

AU - Fay, Francois

AU - Malkus, Joost

AU - Sanchez-Gaytan, Brenda L.

AU - Teunissen, Abraham J.P.

AU - Karakatsanis, Nicolas

AU - Robson, Philip

AU - Zhou, Xianxiao

AU - Ye, Yuxiang

AU - Wojtkiewicz, Gregory

AU - Tang, Jun

AU - Seijkens, Tom T.P.

AU - Kroon, Jeffrey

AU - Stroes, Erik S.G.

AU - Kjaer, Andreas

AU - Ochando, Jordi

AU - Reiner, Thomas

AU - Pérez-Medina, Carlos

AU - Calcagno, Claudia

AU - Fisher, Edward A.

AU - Zhang, Bin

AU - Temel, Ryan E.

AU - Swirski, Filip K.

AU - Nahrendorf, Matthias

AU - Fayad, Zahi A.

AU - Lutgens, Esther

AU - Mulder, Willem J.M.

AU - Duivenvoorden, Raphaël

PY - 2018/8/1

Y1 - 2018/8/1

N2 - In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

AB - In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85050955422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050955422&partnerID=8YFLogxK

U2 - 10.1038/s41551-018-0281-3

DO - 10.1038/s41551-018-0281-3

M3 - Comment/debate

C2 - 31015637

AN - SCOPUS:85050955422

SN - 2157-846X

VL - 2

SP - 623

JO - Nature Biomedical Engineering

JF - Nature Biomedical Engineering

IS - 8

ER -

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this